Clinical Trials Browser

Withdrawn × abiraterone × Clear all

NCT05705700 2023-02-27

Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)

Phase 2 Withdrawn

Prostatic Neoplasms

NCT03173859 2020-11-18

AERA

Phase 2 Withdrawn

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT02380313 2016-10-06

Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone

Phase 1 Withdrawn

Neoplasms